By physician referral or invitation only

Pulmonary Hypertension Drug Study

This study wants to test a inhaled version of an already approved medication for pulmonary hypertension (PH). The purpose is to test its safety and tolerability in group 1 and group 3 PH patients.

Age & Gender

18 years ~ 80 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Jimmy Ford
Medicine-Pulmonary

Study Type

Clinical or Medical
Interventional

Study Topics

Lungs and Breathing

IRB Number

24-0846

ClinicalTrials.gov

NCT06129240

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.